NO954609D0 - Niopecotiske syrederivater som antitrombiske forbindelser - Google Patents
Niopecotiske syrederivater som antitrombiske forbindelserInfo
- Publication number
- NO954609D0 NO954609D0 NO954609A NO954609A NO954609D0 NO 954609 D0 NO954609 D0 NO 954609D0 NO 954609 A NO954609 A NO 954609A NO 954609 A NO954609 A NO 954609A NO 954609 D0 NO954609 D0 NO 954609D0
- Authority
- NO
- Norway
- Prior art keywords
- compounds
- niopecotic
- antithrombic
- acid derivatives
- telet
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US21377294A | 1994-03-16 | 1994-03-16 | |
US36489694A | 1994-12-27 | 1994-12-27 | |
PCT/US1995/003145 WO1995025091A2 (en) | 1994-03-16 | 1995-03-14 | Nipecotic acid derivatives as antithrombic compounds |
Publications (3)
Publication Number | Publication Date |
---|---|
NO954609D0 true NO954609D0 (no) | 1995-11-15 |
NO954609L NO954609L (no) | 1996-01-05 |
NO304885B1 NO304885B1 (no) | 1999-03-01 |
Family
ID=26908383
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO954609A NO304885B1 (no) | 1994-03-16 | 1995-11-15 | Nipectoin syrederivater som antitrombe forbindelser |
Country Status (20)
Country | Link |
---|---|
US (1) | US5770575A (no) |
EP (1) | EP0746545B1 (no) |
JP (1) | JPH09510453A (no) |
KR (1) | KR100328287B1 (no) |
CN (1) | CN1083834C (no) |
AT (1) | ATE180470T1 (no) |
AU (1) | AU703397B2 (no) |
CA (1) | CA2163027A1 (no) |
DE (1) | DE69509875T2 (no) |
DK (1) | DK0746545T3 (no) |
ES (1) | ES2131313T3 (no) |
FI (1) | FI113763B (no) |
GR (1) | GR3030566T3 (no) |
HU (1) | HUT74871A (no) |
MX (1) | MX9504800A (no) |
NO (1) | NO304885B1 (no) |
NZ (1) | NZ283209A (no) |
RU (1) | RU2135470C1 (no) |
TW (1) | TW318179B (no) |
WO (1) | WO1995025091A2 (no) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2157792C (en) * | 1993-09-22 | 2005-05-24 | Mitsuru Ohkubo | N-(3-piperidinyl-carbonyl)-beta-alanine derivatives as paf antagonists |
JPH11502224A (ja) * | 1995-03-17 | 1999-02-23 | 藤沢薬品工業株式会社 | N−アシルピペリジニルカルボニルアミノカルボン酸、およびグリコプロテインIIB/IIIa拮抗剤およびフィブリノーゲン血小板凝集抑制剤としてのその用途 |
WO1997033869A1 (en) * | 1996-03-13 | 1997-09-18 | Fujisawa Pharmaceutical Co., Ltd. | N-[(r)-1-{3-(4-piperidyl)propionyl-3-piperidylcarbonyl]-2(s)-acetylamino-beta-alanine as fibrinogen receptor antagonist |
EP1184374B1 (en) * | 1996-05-01 | 2009-01-28 | Ortho-McNeil Pharmaceutical, Inc. | Carboxamide derivatives of pyrrolidine, piperidine and hexahydroazepine for the treatment of thrombosis disorders |
SK149798A3 (en) * | 1996-05-01 | 1999-10-08 | Ortho Mcneil Pharm Inc | Carboxamide derivatives of pyrrolidine, piperidine and hexahydroazepine for the treatment of thrombosis disorders |
DE19741235A1 (de) * | 1997-09-18 | 1999-03-25 | Hoechst Marion Roussel De Gmbh | Neue Imidazolidinderivate, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate |
US6066651A (en) * | 1997-10-29 | 2000-05-23 | Ortho-Mcneil Pharmaceutical, Inc. | Orally-active nipecotamide glycolamide esters for the treatment of thrombosis disorders |
WO1999025685A1 (en) * | 1997-11-18 | 1999-05-27 | Merck & Co., Inc. | 4-substituted-4-piperidine carboxamide derivatives |
US6020347A (en) * | 1997-11-18 | 2000-02-01 | Merck & Co., Inc. | 4-substituted-4-piperidine carboxamide derivatives |
ES2199805T3 (es) * | 1999-03-22 | 2004-03-01 | Ortho-Mcneil Pharmaceutical, Inc. | Procedimiento para la preparacion de acido (s-(r*s*))-beta-(((1-(1-oxo-3-4-piperidinil)propil)-3-piperidinil)carbonil)amino)-3-piridinoproanoico y derivados. |
AUPQ570100A0 (en) * | 2000-02-17 | 2000-03-09 | Fujisawa Pharmaceutical Co., Ltd. | Beta-alanine derivatives and their use as receptor antagonists |
US20070189970A1 (en) | 2004-02-25 | 2007-08-16 | Astellas Pharma Inc. | Contrast medium for thrombus formation |
EP3184149A1 (en) * | 2015-12-23 | 2017-06-28 | Julius-Maximilians-Universität Würzburg | Soluble glycoprotein v for treating thrombotic diseases |
CN109734655B (zh) * | 2019-03-11 | 2020-06-02 | 都创(上海)医药科技有限公司 | 一种fkbp配体的同型二聚体合成工艺 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4857508A (en) * | 1987-12-03 | 1989-08-15 | Monsanto Company | Novel platelet-aggregation inhibitor peptide derivatives |
US5318899A (en) * | 1989-06-16 | 1994-06-07 | Cor Therapeutics, Inc. | Platelet aggregation inhibitors |
TW201303B (no) * | 1990-07-05 | 1993-03-01 | Hoffmann La Roche | |
MX9100517A (es) * | 1990-08-06 | 1992-04-01 | Smith Kline French Lab | Compuestos |
US5352667A (en) * | 1991-11-22 | 1994-10-04 | Ofer Lider | Non-peptidic surrogates of the Arg-Gly-Asp sequence and pharmaceutical compositions comprising them |
US5219867A (en) * | 1991-12-16 | 1993-06-15 | Research Corporation Technologies, Inc. | Platelet aggregation inhibitory agents |
EP0945504A3 (en) * | 1992-12-11 | 1999-12-08 | The University Of Florida | Materials and method for control of pests |
US5559209A (en) * | 1993-02-18 | 1996-09-24 | The General Hospital Corporation | Regulator regions of G proteins |
-
1995
- 1995-03-06 US US08/395,533 patent/US5770575A/en not_active Expired - Lifetime
- 1995-03-14 ES ES95914023T patent/ES2131313T3/es not_active Expired - Lifetime
- 1995-03-14 DK DK95914023T patent/DK0746545T3/da active
- 1995-03-14 NZ NZ283209A patent/NZ283209A/en unknown
- 1995-03-14 MX MX9504800A patent/MX9504800A/es not_active IP Right Cessation
- 1995-03-14 EP EP95914023A patent/EP0746545B1/en not_active Expired - Lifetime
- 1995-03-14 WO PCT/US1995/003145 patent/WO1995025091A2/en active IP Right Grant
- 1995-03-14 HU HU9503270A patent/HUT74871A/hu unknown
- 1995-03-14 AT AT95914023T patent/ATE180470T1/de not_active IP Right Cessation
- 1995-03-14 CN CN95190367A patent/CN1083834C/zh not_active Expired - Fee Related
- 1995-03-14 RU RU95122287A patent/RU2135470C1/ru not_active IP Right Cessation
- 1995-03-14 JP JP7524128A patent/JPH09510453A/ja active Pending
- 1995-03-14 KR KR1019950705100A patent/KR100328287B1/ko not_active IP Right Cessation
- 1995-03-14 AU AU21191/95A patent/AU703397B2/en not_active Ceased
- 1995-03-14 DE DE69509875T patent/DE69509875T2/de not_active Expired - Fee Related
- 1995-03-14 CA CA002163027A patent/CA2163027A1/en not_active Abandoned
- 1995-11-15 FI FI955498A patent/FI113763B/fi active
- 1995-11-15 NO NO954609A patent/NO304885B1/no unknown
- 1995-12-18 TW TW084113492A patent/TW318179B/zh active
-
1999
- 1999-06-17 GR GR990401649T patent/GR3030566T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
GR3030566T3 (en) | 1999-10-29 |
ES2131313T3 (es) | 1999-07-16 |
AU2119195A (en) | 1995-10-03 |
FI113763B (fi) | 2004-06-15 |
EP0746545A1 (en) | 1996-12-11 |
RU2135470C1 (ru) | 1999-08-27 |
EP0746545B1 (en) | 1999-05-26 |
JPH09510453A (ja) | 1997-10-21 |
ATE180470T1 (de) | 1999-06-15 |
FI955498A (fi) | 1996-01-15 |
DE69509875T2 (de) | 1999-12-09 |
FI955498A0 (fi) | 1995-11-15 |
HU9503270D0 (en) | 1996-05-28 |
CN1128022A (zh) | 1996-07-31 |
WO1995025091A2 (en) | 1995-09-21 |
AU703397B2 (en) | 1999-03-25 |
US5770575A (en) | 1998-06-23 |
NZ283209A (en) | 1998-04-27 |
KR100328287B1 (ko) | 2002-10-11 |
TW318179B (en) | 1997-10-21 |
DE69509875D1 (de) | 1999-07-01 |
DK0746545T3 (da) | 1999-11-08 |
CA2163027A1 (en) | 1995-09-21 |
CN1083834C (zh) | 2002-05-01 |
NO954609L (no) | 1996-01-05 |
HUT74871A (en) | 1997-02-28 |
WO1995025091A3 (en) | 1995-10-12 |
MX9504800A (es) | 1997-05-31 |
NO304885B1 (no) | 1999-03-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO971538L (no) | Purin- og guaninforbindelser som inhibitorer for PNP | |
DK0560268T3 (da) | Substituerede pipecolinsyrederivater som HIV-proteasehæmmere | |
NO954609D0 (no) | Niopecotiske syrederivater som antitrombiske forbindelser | |
PT896533E (pt) | Pentafluorobenzenosulfonamidas e analogos | |
DK0594702T3 (da) | Substituerede indoler som midler mod AIDS | |
NO963370L (no) | Nye mercaptoacetylamido-1,3,4,5-tetrahydrobenzo[cÅazepin-3-on-disulfidderivater som er anvendbare som inhibitorer av enkefalinase og ACE | |
PT923554E (pt) | N-benzilpiperidina e derivados tetrahidropiridina | |
EA200200510A1 (ru) | 4-карбоксиамино-2-этил-1,2,3,4-тетрагидрохинолин в кристаллической форме как ингибитор сетр | |
EA200000826A1 (ru) | Галоидированные производные амидиноаминокислот, применимые в качестве ингибиторов no-синтазы | |
NO972887D0 (no) | Piperidineddiksyrederivater anvendelige som fibrinogen-antagonistmiddel | |
NO20022977L (no) | Substituerte homopiperidinylbenzimidazolanaloger som fundiske relaksanter | |
ES2168355T3 (es) | Derivados de bisulfuro de indano-2-mercaptoacetilamida utiles como inhibidores de la encefalinasa. | |
DE69527854D1 (de) | Derivate substituierter amidinonaphthylester | |
FI960588A (fi) | Mikrobisideina käytettäviä tiokarbamoyyliyhdisteitä | |
NO995132D0 (no) | Fremgangsmåte for reduksjon av fibrinogen | |
NO950212D0 (no) | Indolinyl-N-hydroksyurinstoff- og -N-hydroksamsyrederivater som lipoksygenase-inhibitorer | |
GT199400074A (es) | Pirroles substituidos | |
AR005835A1 (es) | Derivados aromaticos sustituidos del acido fosfonico. | |
NO20012328D0 (no) | Fluorerte 3,4-dihydrokinolinderivater anvendt som NOS- inhibitorer |